Abstract:Background: Healthcare costs in most developed countries are not clearly linked to better patient and public health outcomes, but are rather associated with service delivery orientation. In the U.S. this has resulted in large variation in healthcare availability and use, increased cost, reduced employer participation in health insurance programs, and reduced overall population health outcomes. Recent U.S. healthcare reform legislation addresses only some of these issues. Other countries face similar healthcare issues. Discussion: A major goal of healthcare is to enhance patient health outcomes. This objective is not realized in many countries because incentives and structures are currently not aligned for maximizing population health. The misalignment occurs because of the competing interests between "actors" in healthcare. In a simplified model these are individuals motivated to enhance their own health; enterprises (including a mix of nonprofit, for profit and government providers, payers, and suppliers, etc.) motivated by profit, political, organizational and other forces; and government which often acts in the conflicting roles of a healthcare payer and provider in addition to its role as the representative and protector of the people. An imbalance exists between the actors, due to the resources and information control of the enterprise and government actors relative to the individual and the public. Failure to use effective preventive interventions is perhaps the best example of the misalignment of incentives. We consider the current Pareto efficient balance between the actors in relation to the Pareto frontier, and show that a significant change in the healthcare market requires major changes in the utilities of the enterprise and government actors. Summary: A variety of actions are necessary for maximizing population health within the constraints of available resources and the current balance between the actors. These actions include improved transparency of all aspects of medical decision making, greater involvement of patients in shared medical decision making, greater oversight of guideline development and coverage decisions, limitations on direct to consumer advertising, and the need for an enhanced role of the government as the public advocate.

Linking Cost Sharing to Value: An Unrivaled Yet Unrealized Public Health Opportunity

Why Cost Sharing Alone Will Not Fix Health Care Costs

Cost sharing in managed care and the ethical question of business purpose

It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties

The effects of patient cost sharing on inpatient utilization, cost, and outcome

Economic evaluation in the US: what is the missing link?

More for less: best patient outcomes in a time of financial restraint

How to Pay for Health Care

The impact of telehealth cost-sharing on healthcare utilization: Evidence from high-deductible health plans

Inequities in Unexpected Cost-Sharing for Preventive Care in the United States

Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a "Shared Savings" Approach to Cost Offsets

Functional status care categories and national health policy

The Case for Capitation

Utilitarianism and the ethical foundations of cost-effectiveness analysis in resource allocation for global health

Health technology assessment (HTA) and economic evaluation: efficiency or fairness first

Addressing the distributional consequences of spillovers in health economic evaluation: A prioritarian approach

Balancing influence between actors in healthcare decision making

Is the Centralization of Complex Surgical Procedures an Unintended Spillover Effect of Global Capitation? – Insights from the Maryland Global Budget Revenue Program

Effects of mixed provider payment systems and aligned cost sharing practices on expenditure growth management, efficiency, and equity: a structured review of the literature

Physician patient-sharing networks and the cost and intensity of care in US hospitals

[High-cost therapy. Ethical principles of allocation of scarce resources]